This study was performed to compare the safety and efficacy of intravaginal micoprostol versus prostaglandin(PG)E2 for labor induction in term pregnancies. One hundred seventy-two pregnant women opting for labor induction with randomly were allocated ...
This study was performed to compare the safety and efficacy of intravaginal micoprostol versus prostaglandin(PG)E2 for labor induction in term pregnancies. One hundred seventy-two pregnant women opting for labor induction with randomly were allocated to two groups, receiving either 50 micro g misoprostol every four hours with maximum six times or 3 mg PGE2 vaginal tablet every eight hours with maxiumum three times, intravaginally in the posterior vaginal formix. No labor was initiated after maximum does of misoprostol or PGE2 vaginal tablet, or dystocia occurred during active phase of laobr, intravenous infusion of oxytocin was administrated. There were no differences in clinical characteristics between the misoprostol and the PGWE2 vaginal tablet group. Change of the Bishop score was more effetive in misoprostol group thean PGE2 vaginal tablet group at four hours(p